[1] Guerreso K, Conner EA. Possible role of anti-SSA/Ro antibodies in the pathogenesis of pulmonary hypertension[J].Respiratory Med Case Rep,2016, 17(C):47-49. [2] Sanges S, Yelnik C M, Sitbon O, et al. Pulmonary arterial hypertension in idiopathic inflammatory myopathies:Data from the French pulmonary hypertension registry and review of the literature[J].Medicine(Baltimore),2016, 95(39):e4911. [3] Li J, Leng X, Li Z, et al. Chinese SLE treatment and research group registry: III. association of autoantibodies with clinical manifestations in Chinese patients with systemic lupus erythematosus[J].Res J Immunol,2014, 2014(1):809389. [4] Huang C, Li M, Liu Y, et al. Baseline characteristics and risk factors of pulmonary arterial hypertension in systemic lupus erythematosus patients[J].Medicine(Baltimore)2016, 95(10):e2761. [5] Higgs R, Ní Gabhann J, Ben Larbi N. The E3 ubiquitin ligase Ro52 negatively regulates IFN-beta production post-pathogen recognition by polyubiquitin-mediated degradation of IRF3[J].J Immunol,2008, 181(3):1780. [6] Rowan H, Elisa L, Claire W, et al. Self-Protection from Anti-Viral Responses-Ro52 Promotes Degradation of the Transcription Factor IRF7 Downstream of the Viral Toll-Like Receptors[J].PLoS One,2010, 5(7):e11776. [7] George PM, Oliver E, Dorfmüller P, et al. Evidence for the involvement of type I interferon in pulmonary arterial hypertension[J].Circ Res,2014,114(4):677-688. [8] Badiger R, Mitchell JA, Gashaw H, et al. Effect of different interferon preparations on IP10 and ET-1release from human lung cells[J].PLoS One,2012, 7(10): e46779. [9] Nakano M, Fujii T, Hashimoto M, et al. Type I interferon induces CX3CL1 (fractalkine) and CCL5 (RANTES) production in human pulmonary vascular endothelial cells[J].Clin Exp Immunol,2012, 170(1):94-100. [10] Kim K J, Baek I W, Yoon C H, et al. Anemic hypoxia is associated with increased pulmonary artery systolic pressure in patients with systemic lupus erythematosus.[J].Arthritis Care Res,2015, 67(12):1702-1711. [11] Takaoka A, Yanai H, Kondo S, et al. Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors[J].Nature,2005, 434(7030):243-249. [12] Espinosa A, Dardalhon V S. Loss of the lupus autoantigen Ro52/Trim21 induces tissue inflammation and systemic autoimmunity by disregulating the IL-23-Th17 pathway[J].J Exp Med,2009, 206(8):1661-1671. [13] Niida M, Tanaka M, Kamitani T. Downregulation of active IKKβ by Ro52-mediated autophagy[J].Mol Immunol,2010, 47(14):2378-2387. [14] Wada K, Niida M, Tanaka M, et al. Ro52-mediated monoubiquitination of IKK{beta down-regulates NF-kappa B signalling[J].J Biochem,2009, 146(6):821-832. [15] Lisi S,Sisto M,Lofrumento DD.Sjgren's syndrome autoantibodies provoke changes in gene expression profiles of inflammatory cytokines triggering a pathway involving TACE/NF-κB[J].Lab Invest,2012,92(4):615-624.
2019, Vol. 36 
